Orion to sell Orion Diagnostica

Name: Aidian
Price range: $

Orion has signed an agreement on the sale of all shares in Orion Diagnostica Oy to an investment fund managed by Axcel Management A/S, a leading Nordic private equity investment company. The closing of the transaction is expected to take place during the second quarter of 2018.

"We are eager to partner with Axcel as we continue to execute our growth strategy” says Kaisa Tarkkanen, President of Orion Diagnostica. “Axcel is an ideal partner to support our strategy with an approach fitting well with our culture and strong commitment to delivering excellent customer solutions”, she adds.

Read Orion press release: https://www.orion.fi/en/Orion-group/media/stock-exchange-releases/2018/orion-to-sell-its-orion-diagnostica-division---due-to-the-transaction-orion-updates-its-outlook/

COVID-19 and Strep A can co-occur – remember to test also for other pathogens

Critical care blood gas analysis with Stat Profile Prime Plus®

Julhälsningar från Aidian

COVID-19 and Strep A can co-occur – remember to test also for other pathogens

Critical care blood gas analysis with Stat Profile Prime Plus®

Orion to sell Orion Diagnostica

Föreslagna ämnen

Populära produkter

Senaste nyheter

COVID-19 and Strep A can co-occur – remember to test also for other pathogens

Critical care blood gas analysis with Stat Profile Prime Plus®

Julhälsningar från Aidian

Nyheter

COVID-19 and Strep A can co-occur – remember to test also for other pathogens

Critical care blood gas analysis with Stat Profile Prime Plus®

Denna webbplats använder kakor

Vi använder kakor för att kunna rikta relevant innehåll och annonser till dig, för att kunna analysera trafiken och för att vi ska kunna säkerställa att tjänsterna fungerar som de ska.

Nödvändiga (Obligatorisk)

Statistik

Marknadsföring